Sign in

CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460920988
Phone
805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Open-market sale Chief Financial Officer sold 3,616 shares at $14.55 ($52,613)
  2. 4 Open-market sale Chief Commercial Officer sold 761 shares at $14.55 ($11,073)
  3. 4 Open-market sale Chief Operations Officer sold 3,500 shares at $15.00 ($52,500)
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 4 Open-market sale Chief Operations Officer sold 655 shares at $14.74 ($9,655)
  9. 4 Open-market sale Chief Financial Officer sold 1,761 shares at $14.58 ($25,675)
  10. 4 Open-market sale Chief Operations Officer sold 2,640 shares at $14.58 ($38,491)
  11. 4 Open-market sale Chief Operations Officer sold 7,000 shares at $17.41 ($121,870)
  12. 4 Open-market sale Chief Operations Officer sold 1,665 shares at $16.74 ($27,872)
  13. 4 Open-market sale Chief Financial Officer sold 1,461 shares at $16.74 ($24,457)
  14. 4 Open-market sale President and CEO sold 4,887 shares at $16.74 ($81,808)
  15. 4 Grant or award EVP, Head of R&D acquired 53,879 shares (grant or award)
  16. 4 Grant or award SVP, GC & Secretary acquired 41,756 shares (grant or award)
  17. 4 Grant or award Chief Operations Officer acquired 37,715 shares (grant or award)
  18. 4 Grant or award Chief Commercial Officer acquired 35,021 shares (grant or award)
  19. 4 Grant or award Chief Financial Officer acquired 45,258 shares (grant or award)
  20. 4 Grant or award President and CEO acquired 117,187 shares (grant or award)

Page 22 of 57 · 1,133 filings